Healthcare - Biotechnology - NASDAQ - US
$ 1.69
-1.17 %
$ 81.6 M
Market Cap
-1.37
P/E
BALANCE SHEET
192 M
ASSETS
22.3 M
LIABILITIES
170 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Ikena Oncology, Inc.
| Current Assets | 179 M |
| Cash & Short-Term Investments | 175 M |
| Receivables | 0 |
| Other Current Assets | 3.2 M |
| Non-Current Assets | 13.4 M |
| Long-Term Investments | 0 |
| PP&E | 8.02 M |
| Other Non-Current Assets | 5.41 M |
| Current Liabilities | 14.2 M |
| Accounts Payable | 2.07 M |
| Short-Term Debt | 7.12 M |
| Other Current Liabilities | 5.02 M |
| Non-Current Liabilities | 8.13 M |
| Long-Term Debt | 7.18 M |
| Other Non-Current Liabilities | 950 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 119.9 | 59.9 | 232.2 | 162.5 | 82.1 | 18.2 |
| Short Term Investments | 55.6 | 97.0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.2 | 3.1 | 4.3 | 3.5 | 3.1 | 1.8 |
| Total Current Assets | 178.7 | 160.0 | 236.5 | 166.0 | 85.2 | 20.0 |
| PP&E | 8.0 | 8.5 | 9.0 | 1.6 | 0.8 | 0.7 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.9 | 2.4 | 0.9 | 0 | 0 |
| Other Long Term Assets | 5.4 | 2.9 | 0 | 0 | (0.8) | 1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 1 |
| Total Assets | 192.1 | 172.3 | 247.9 | 168.4 | 86.0 | 20.7 |
| LIABILITIES | ||||||
| Accounts Payable | 2.1 | 2.1 | 2.4 | 2.1 | 0.9 | 2.3 |
| Short Term Debt | 7.1 | 3.8 | 3.7 | (17.6) | 0 | 0 |
| Other Current Liabilities | 5.0 | 6.4 | 4.0 | 5.0 | 2.6 | 1.6 |
| Total Current Liabilities | 14.2 | 21.5 | 27.2 | 28.3 | 24.3 | 3.8 |
| Long Term Debt | 7.2 | 3.8 | 5.1 | 0 | 78.9 | 62.6 |
| Deferred Tax Income | 0 | 0 | (7.7) | (206.0) | (78.9) | 0 |
| Other Liabilities | 0.9 | 0 | 0 | 206.0 | 0 | 0 |
| Total Liabilities | 22.3 | 25.3 | 40.0 | 269.5 | 147.4 | 66.5 |
| EQUITY | ||||||
| Common Stock | 48 K | 36 K | 36 K | 3 K | 3 K | 19 K |
| Retained Earnings | (282.4) | (214.2) | (145.5) | (111.3) | (67.1) | (50.3) |
| Other Accumulative Comprehensive Income/Loss | 48 K | (0.8) | (247.9) | (206.0) | (78.9) | 0 |
| Total Equity | 169.8 | 147.0 | 207.9 | (101.0) | (61.5) | (45.8) |
| Total Liabilities and Equity | 192.1 | 172.3 | 247.9 | 168.4 | 86.0 | 20.7 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 41.7 | 36.2 | 36.0 | 35.9 | 35.9 | 35.9 |